Kennebec Region Health Alliance

Promoting Healthy Communities Since 1997

Medicare ACO - Kennebec Region Health Alliance

ACO Name and Location

Kennebec Region Health Alliance
10 Water Street
Waterville, Maine 04330

ACO Primary Contact

Primary Contact Name:Barbara Crowley, MD
Primary Contact Phone Number:207-626-1097
Primary Contact Email Address:

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Kennebec Anesthesia Associates, P.A. Y
Pathology Associates, Pa Y
Waterville Family Practice Y
Michael Szela Y
Hallowell Family Practice LLC Y
Mainegeneral Medical Center Y
Maranacook Family Health Care, LLC PA Y
Michael Szela Y
Radiology Alliance of Maine LLC Y

 

ACO governing body:

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Burke John Chair, KRHA Medical Director 0 ACO Chairperson, ACO Medical Director MaineGeneral Medical Center
Crowley Barbara Director, KRHA President 1 ACO Participant Representative MaineGeneral Medical Center
Souders Mark Director, KRHA Treasurer/Secretary 1 ACO Participant Representative MaineGeneral Medical Center
Madden Amy Director 1 ACO Participant Representative MaineGeneral Medical Center
Szela Michael Director 1 ACO Participant Representative Michael Szela
Brann Terry Director 1 ACO Participant Representative MaineGeneral Medical Center
Gagliardi Paul Director 1 ACO Participant Representative Radiology Alliance of Maine LLC
Diaz Steve Director 1 ACO Participant Representative MaineGeneral Medical Center
Dionne Andrew Direcotr 1 ACO Participant Representative MaineGeneral Medical Center
Hay David Director 1 ACO Participant Representative MaineGeneral Medical Center
Hays Charles Director 1 ACO Participant Representative MaineGeneral Medical Center
Brown Benjamin Director 1 ACO Participant Representative MaineGeneral Medical Center
Arbour Sandra Director 1 Medicare Beneficiary N/A

 

 Key ACO clinical and administrative leadership:

Barbara Crowley: ACO Executive
John Burke: Medical Director
Margaret Naas: Compliance Officer
 

 

Associated committees and committee leadership:

Committee Name
Committee Leader Name and Position
Clinical Integration Committee John Burke, MD, Chairperson
Quality Improvement Committee Monica Beaulieu, Chairperson
Finance Committee Mark Souders, Chairperson
Utilization Review Committee John Burke, MD, Chairperson

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

 

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 79.9
ACO-2 CAHPS: How Well Your Providers Communicate N/A 92.63
ACO-3 CAHPS: Patients' Rating of Provider N/A 91.93
ACO-4 CAHPS: Access to Specialists N/A 83.52
ACO-5 CAHPS: Health Promotion and Education N/A 60
ACO-6 CAHPS: Shared Decision Making N/A 75.28
ACO-7 CAHPS: Health Status/Functional Status N/A 71.82
ACO-34 CAHPS: Stewardship of Patient Resources N/A 27.52
ACO-8 Risk-Standardized, All Condition Readmission N/A 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented N/A 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam   N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.  

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

Contact Us

Kennebec Region Health Alliance
10 Water Street, Suite 202
Waterville, ME 04901
(207) 873-9842

Compliance Helpline
(207) 621-9870